As exciting as all this sounds, we have a long way to go to see if this hopeful hypothesis about GLP-1 agonist medications is correct
As weight loss progresses with Ozempic, improvements in blood pressure and blood sugar control are common, which could mean that dosages of other medications, including amlodipine, might need adjustment over time
Colchicine has been studied in long COVID and failed to improve functional capacity, respiratory function, or inflammatory markers
The situation might change soon
Follow-up Patients were followed from the index date (the date of GLP-1 receptor agonist prescription) until death, loss to follow-up, or the end of the study period (December 1, 2025), whichever occurred first
Adherence to local and international safety protocols, including SDS handling and PPE